OraSure Technologies, Inc. announced a commercial collaboration with Targeted Genomics LLC, the developer of GlutenID. This partnership will expand consumer access to at-home celiac genetic testing.
The collaboration will utilize OraSure's ORAcollect®·Dx, which is the only FDA-cleared saliva collection device approved for general over-the-counter (OTC) use. GlutenID is the first and only U.S. Food and Drug Administration (FDA) cleared direct-to-consumer (DTC) test for celiac disease genetics.
This collaboration leverages OraSure's established sample collection technology to enter the growing direct-to-consumer genetic testing market for celiac disease. It represents a strategic expansion for the ORAcollect®·Dx device into a new diagnostic application.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.